Revenue

An InsurTech spin-off is slashing costs and speeding up agent onboarding, setting a new benchmark for a legacy industry resistant to change.

With a fresh $40M in funding, Letter AI is challenging sales tech incumbents by moving beyond static playbooks to real-time, deal-specific AI guidance.

A new report on 1,800+ patients reveals a model for obesity care that preserves muscle, sustains weight loss, and may solve the GLP-1 cost crisis.

A global leader in OEM security is recognized for its inCompass platform, which silently protects billions from escalating mobile and encrypted threats.

With a massive Series A, Alveus Therapeutics is advancing novel drugs aiming for more durable and higher-quality weight loss than current blockbusters.

A new GenAI chatbot is replacing frustrating product manuals, earning a top award and signaling a major shift in customer experience for retail.

Dr. Frank Smith joins XenoSTART to lead its preclinical unit, aiming to leverage its vast patient-derived model library to speed up oncology drug development.

Leading crypto ATM operator Bitcoin Depot now requires ID for every transaction, a move aimed at fighting fraud but raising questions about user access.

Hyperlink InfoSystem unveils AI agents promising to slash operational costs by up to 90%, signaling a major shift in workforce and business strategy.

After a pivotal trial failure, Alector will present its new strategy at a key health conference, focusing on its innovative brain-delivery platform.

Fort Worth Plastic Surgery's new partnership with a PE-backed group highlights a major industry shift, raising questions about growth, autonomy, and patient care.

The merger, backed by private equity, creates a dominant force in higher education services, aiming to tackle digital transformation and student success.

With 80% of Indian diets lacking protein, the fast-food giant is serving up a science-backed solution. But can a burger truly bridge a national nutrition gap?

The maker of Wegovy and Ozempic announces a massive price cut. We explore what this means for patients, competitors, and the future of drug pricing.

A new voter tool uses AI to score Texas primary candidates on collaboration over conflict, aiming to reshape how voters choose their representatives.

Lithium developer Stardust Power partners with a Pentagon-aligned group, a critical move to reduce foreign reliance and fuel the U.S. energy transition.

Leaving the volatile crypto world behind, Cipher Digital is raising billions to build massive data centers for tech giants like AWS and Google.

Larimar Therapeutics' nomlabofusp receives Breakthrough Therapy Designation, paving an accelerated path for a potential disease-modifying treatment.

The bioprocessing leader posted robust 2025 earnings, outperforming the market with strategic innovation and a major expansion into Asian markets.

Facing SEC delays, Aptose Biosciences secures an $11.1M lifeline from its acquirer, Hanmi, highlighting financial strain as the critical deal moves forward.